|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
YUREDOL * is indicated in the management of acute muscle spasm and pain and / or secondary to trauma, muscle strain, tendon and ligaments, back pain, stiff neck, dislocations, sprains, fractures, myalgia, fibrositis (fibromyalgia), cervical or lumbosacral radiculopathy, osteoarthritis degenerative and other categories of locomotor splenic accompanying muscle spasms and pain. It is especially useful in controlling post-extraction of third molar trismus. No action when the muscle spasm due to central nervous system lesions.
Arrhythmias, cardiac conduction disturbances, congestive heart failure, recent myocardial infarction, hyperthyroidism, active peptic ulcer, gastrointestinal bleeding, hypersensitivity to the components of the formula.
Drowsiness, dry mouth and dizziness. Ocasionalmente debilidad, occasionally, weakness, fatigue, dyspnea, nausea, numbness, bad taste in mouth, blurred vision, insomnia, tachycardia, headache and constipation. Exceptionally urinary retention and / or urinary incontinence, skin rashes of allergic origin, confusion, ataxia and tremor.
YUREDOL * may decrease the antihypertensive effect of guanethidine. May potentiate the toxicity of CNS depressants and anticholinergics. hypertensive crisis may occur if you previously have been receiving these drugs are recommended interval of 14 days leave before starting treatment with YUREDOL *. They should not drink alcoholic beverages while being treated with YUREDOL *.The painkiller clonixinate lysine does not alter coagulation, no interaction with anticoagulant drugs and do not require dose adjustments.
YUREDOL * should be used with caution in patients with a history of peptic ulcer, urinary retention, angle-closure glaucoma or increased intraocular pressure, epilepsy, liver or renal failure and hypertension. Because YUREDOL * may cause drowsiness, patients should not drive motor vehicles, operate specialized machinery or engage in activities that require a high degree of concentration. Elderly patients are more susceptible to adverse effects, especially anticholinergic type.
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Dr. Talal Sabouni
Dr. Hani Najjar
Dr. Samer Al-Jneidy
Yaser Habrawi , F.R.C.S.Ed
Dr. Faisal Dibsi
Samir Moussa M.D.
Dr . Dirar Abboud
Dr. Tahsin Martini